Understanding PTPRS in Rheumatoid Arthritis

Role of PTPRS in Rheumatoid Arthritis

['FUNDING_R01'] · CEDARS-SINAI MEDICAL CENTER · NIH-11124816

This work explores how a protein called PTPRS contributes to rheumatoid arthritis, hoping to find new ways to help patients.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorCEDARS-SINAI MEDICAL CENTER (nih funded)
Locations1 site (LOS ANGELES, UNITED STATES)
Trial IDNIH-11124816 on ClinicalTrials.gov

What this research studies

In rheumatoid arthritis, special cells in the joints called fibroblast-like synoviocytes (FLS) cause inflammation and damage. This project aims to understand how a specific protein, PTPRS, works within these FLS cells and how it is controlled. Researchers have found that PTPRS makes FLS more aggressive, and they've developed a way to change PTPRS's function using a special decoy fragment. This decoy has shown promise in reducing arthritis in animal models, suggesting a new path for treatment.

Who could benefit from this research

Good fit: This foundational work is for future patients living with rheumatoid arthritis who might benefit from new, targeted therapies.

Not a fit: Patients without rheumatoid arthritis would not directly benefit from this specific research.

Why it matters

Potential benefit: If successful, this work could lead to new medications that specifically target joint-damaging cells in rheumatoid arthritis, potentially offering a different approach to treatment.

How similar studies have performed: Previous work in this grant's first phase successfully identified PTPRS as a key regulator of FLS aggressiveness and developed an approach to modulate its function.

Where this research is happening

LOS ANGELES, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.